Type I interferon production in HIV-infected patients
Authors:
- 17 August 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 80 (5) , 984-993
Abstract
Type I IFNs display multiple biological effects. They have a strong antiviral action, not only directly but also indirectly through activation of the immune system. They may also have actions that are deleterious for the host. The cells that produce type I IFN are mostly plasmacytoid dendritic cells (pDC), but this depends on the viral stimulus. The migration and distribution of pDC into lymphoid organs, driven by chemokine interactions with their ligands, determines interaction with different cell types. In HIV infection, IFN production in vitro is impaired during primary infection and later in association with opportunistic infections. Circulating pDC numbers are decreased in parallel. These parameters may be used to help assess the prognosis of the disease and to monitor treatment.Keywords
This publication has 190 references indexed in Scilit:
- TRBP, a regulator of cellular PKR and HIV‐1 virus expression, interacts with Dicer and functions in RNA silencingEMBO Reports, 2005
- TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencingNature, 2005
- Dendritic and Natural Killer Cell Subsets Associated with Stable or Declining CD4+Cell Counts in Treated HIV‐1–Infected ChildrenThe Journal of Infectious Diseases, 2005
- Viruses Evade the Immune System through Type I Interferon-Mediated STAT2-Dependent, but STAT1-Independent, SignalingImmunity, 2005
- Dendritic cells respond to influenza virus through TLR7‐ and PKR‐independent pathwaysEuropean Journal of Immunology, 2004
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Interferon-α generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infectionAIDS, 2001
- Interferons α and β as Immune Regulators—A New LookImmunity, 2001
- Experimental gene therapyAIDS, 1997
- Decreased Frequency of Functional Natural Interferon-Producing Cells in Peripheral Blood of Patients with the Acquired Immune Deficiency SyndromeClinical Immunology and Immunopathology, 1994